These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28762205)

  • 21. Tailoring the AAV vector capsid for gene therapy.
    Vandenberghe LH; Wilson JM; Gao G
    Gene Ther; 2009 Mar; 16(3):311-9. PubMed ID: 19052631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Engineering of AAV Capsid Gene for Gene Therapy Application.
    Liu Y; Zhang X; Yang L
    Curr Gene Ther; 2020; 20(5):321-332. PubMed ID: 32998676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transposon-based mutagenesis generates diverse adeno-associated viral libraries with novel gene delivery properties.
    Koerber JT; Schaffer DV
    Methods Mol Biol; 2008; 434():161-70. PubMed ID: 18470644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
    Liu Y; Siriwon N; Rohrs JA; Wang P
    Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adeno-associated virus (AAV) vectors in cancer gene therapy.
    Santiago-Ortiz JL; Schaffer DV
    J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing.
    Adachi K; Enoki T; Kawano Y; Veraz M; Nakai H
    Nat Commun; 2014; 5():3075. PubMed ID: 24435020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of AAV vectors to target persistent viral reservoirs.
    Colón-Thillet R; Jerome KR; Stone D
    Virol J; 2021 Apr; 18(1):85. PubMed ID: 33892762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.
    Castle MJ; Turunen HT; Vandenberghe LH; Wolfe JH
    Methods Mol Biol; 2016; 1382():133-49. PubMed ID: 26611584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adeno-associated virus serotypes for gene therapeutics.
    Lisowski L; Tay SS; Alexander IE
    Curr Opin Pharmacol; 2015 Oct; 24():59-67. PubMed ID: 26291407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
    Yang L; Li J; Xiao X
    Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery.
    Carneiro A; Lee H; Lin L; van Haasteren J; Schaffer DV
    Hum Gene Ther; 2020 Sep; 31(17-18):996-1009. PubMed ID: 32799685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification and labeling of AAV vector particles.
    Büning H; Bolyard CM; Hallek M; Bartlett JS
    Methods Mol Biol; 2011; 807():273-300. PubMed ID: 22034035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy.
    Rodríguez-Márquez E; Meumann N; Büning H
    Expert Opin Biol Ther; 2021 Jun; 21(6):749-766. PubMed ID: 33331201
    [No Abstract]   [Full Text] [Related]  

  • 34. A multiplexed barcode approach to simultaneously evaluate gene delivery by adeno-associated virus capsid variants in nonhuman primates.
    Stone D; Meumann N; Kuhlmann AS; Peterson CW; Xie H; Roychoudhury P; Loprieno MA; Vu XK; Strongin DE; Kenkel EJ; Haick A; Stensland L; Obenza WM; Parrott J; Nelson V; Murnane RD; Huang ML; Aubert M; Kiem HP; Büning H; Jerome KR
    Hepatol Commun; 2023 Feb; 7(2):e0009. PubMed ID: 37074875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
    Schön C; Biel M; Michalakis S
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy.
    Wagner HJ; Weber W; Fussenegger M
    Adv Sci (Weinh); 2021 May; 8(9):2004018. PubMed ID: 33977059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV ancestral reconstruction library enables selection of broadly infectious viral variants.
    Santiago-Ortiz J; Ojala DS; Westesson O; Weinstein JR; Wong SY; Steinsapir A; Kumar S; Holmes I; Schaffer DV
    Gene Ther; 2015 Dec; 22(12):934-46. PubMed ID: 26186661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Capsid assembly and DNA encapsidation of adeno-associated virus].
    Wang Q; Lü Y; Li Z; Diao Y; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):531-8. PubMed ID: 21847986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors.
    Pekrun K; De Alencastro G; Luo QJ; Liu J; Kim Y; Nygaard S; Galivo F; Zhang F; Song R; Tiffany MR; Xu J; Hebrok M; Grompe M; Kay MA
    JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AAV hybrid serotypes: improved vectors for gene delivery.
    Choi VW; McCarty DM; Samulski RJ
    Curr Gene Ther; 2005 Jun; 5(3):299-310. PubMed ID: 15975007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.